The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Pathological Changes in Alzheimer’s Disease Analyzed Using Induced Pluripotent Stem Cell-Derived Human Microglia-Like Cells
Abstract
Microglia constitute the majority of innate immune cells in the brain, and their dysfunction is associated with various central nervous system diseases. Human microglia are extremely difficult to obtain experimentally, thereby limiting studies on their role in complex diseases. Microglia derived from human stem cells provide new tools to assess the pathogenesis of complex diseases and to develop effective treatment methods. This study aimed to develop a reliable method to derive human microglial-like cells (iMGLs) from induced pluripotent stem cells (iPSCs) expressing microglia-specific markers IBA1 and TMEM119 and respond to lipopolysaccharide (LPS) stimulation. Thereafter, we compared iMGL functions from Alzheimer's disease (AD) patients and cognitive normal controls (CNCs). AD-iMGLs displayed stronger phagocytic ability with or without stimulation. High LPS concentrations (>2μg/ml) caused death in CNC-iMGLs, while AD-iMGLs did not display significant cell death. Cytokine analysis revealed that TNF-α, IL-6, and IL-10 secreted by AD-iMGLs were significantly increased upon LPS stimulation compared to those in CNC-iMGLs. The present results indicate that AD-iMGLs exhibit significant inflammatory characteristics and can reflect some pathological changes in microglia in AD, thereby providing new valuable tools to screen candidate drugs for AD and to elucidate the mechanisms underlying AD pathogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Evidence from iPSC-derived microglia obtained from sporadic AD patients is scarce.
“Currently, evidence from iPSC-derived microglia obtained from sporadic AD patients is scarce [123].”
From microRNA-132 attenuates inflammation in induced pluripotent stem cell-derived microglia from Alzheimer’s disease patients (2026) · cites this paper as [123]
Citations
Cites
Microglial Dysfunction and Defective β-Amyloid Clearance Pathways in Aging Alzheimer's Disease Mice
Hickman, S. E., Allison, E. K., & El Khoury, J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0616-08.2008 · Cited by 1,329 · cited 1×
“Datawereanalyzedusingtwo-wayANOVA,followedbySidak’smultiplecomparisonstest(Theexperimentsperformedintriplicate); ∗ p <0.05, ∗∗ p <0.01, ∗∗∗ p <0.001. phagocytosis is significantly reduced [41].”
InfluentialMicroglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease
Prinz, M., & Priller, J. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3722 · Cited by 1,329
Lin, Y.-T., Seo, J., Gao, F., Feldman, H. M., Wen, H.-L., Penney, J., Cam, H. P., Gjoneska, E., Raja, W. K., Cheng, J., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.05.008 · Cited by 1,125
Jay, T. R., Miller, C. M., Cheng, P. J., Graham, L. C., Bemiller, S., Broihier, M. L., Xu, G., Margevicius, D., Karlo, J. C., Sousa, G. L., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20142322 · Cited by 682
Microglia: Dynamic Mediators of Synapse Development and Plasticity
Wu, Y., Dissing-Olesen, L., MacVicar, B. A., & Stevens, B. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.08.008 · Cited by 661
Haenseler, W., Sansom, S. N., Buchrieser, J., Newey, S. E., Moore, C. S., Nicholls, F. J., Chintawar, S., Schnell, C., Antel, J. P., Allen, N. D., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.05.017 · Cited by 593
Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease
Fuhrmann, M., Bittner, T., Jung, C. K. E., Burgold, S., Page, R. M., Mitteregger, G., Haass, C., LaFerla, F. M., Kretzschmar, H., & Herms, J. (2010) · Nature Neuroscience · doi:10.1038/nn.2511 · Cited by 562
Parvathenani, L. K., Tertyshnikova, S., Greco, C. R., Roberts, S. B., Robertson, B., & Posmantur, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209478200 · Cited by 488
Smith, A. M., & Dragunow, M. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2013.12.001 · Cited by 256 · cited 1×
“Since the applications of primary human microglia are severely limited, most of our studies on microglia involve animal models and immortalized cell lines, both quite different from primary human microglia [9, 10].”
GM‐CSF promotes proliferation of human fetal and adult microglia in primary cultures
Lee, S. C., Liu, W., Brosnan, C. F., & Dickson, D. W. (1994) · Glia · doi:10.1002/glia.440120407 · Cited by 209
The role of microglial P2X7: modulation of cell death and cytokine release
He, Y., Taylor, N., Fourgeaud, L., & Bhattacharya, A. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0904-8 · Cited by 194
Smith, A. M., Gibbons, H. M., Lill, C., Faull, R. L. M., & Dragunow, M. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-520-0_6 · Cited by 18
Flagged first, then by citations
Research works printed but not linked: 40
- Ginhoux, 2010, Fate mapping analysis reveals that adult microglia derive from primitive macrophages, Science, 330, 841, 10.1126/science.1194637 · DOI · Paper page
- Ransohoff, 2010, The myeloid cells of the central nervous system parenchyma, Nature, 468, 253, 10.1038/nature09615 · DOI · Paper page
- Hefendehl, 2014, Homeostatic and injury-induced microglia behavior in the aging brain, Aging Cell, 13, 60, 10.1111/acel.12149 · DOI · Paper page
- Davalos, 2005, ATP mediates rapid microglial response to local brain injury in vivo, Nat Neurosci, 8, 752, 10.1038/nn1472 · DOI · Paper page
- Azevedo, 2013, Activated microglia mediate synapse loss and short-term memory deficits in a mouse model of transthyretin-related oculoleptomeningeal amyloidosis, Cell Death Dis, 4, e789, 10.1038/cddis.2013.325 · DOI
- Orre, 2014, Isolation of glia from Alzheimer’s mice reveals inflammation and dysfunction, Neurobiol Aging, 35, 2746, 10.1016/j.neurobiolaging.2014.06.004 · DOI · Paper page
- Condello, 2015, Microglia constitute a barrier that prevents neurotoxic protofibrillar Abeta42 hotspots around plaques, Nat Commun, 6, 6176, 10.1038/ncomms7176 · DOI · Paper page
- Salter, 2014, Sublime microglia: Expanding roles for the guardians of the CNS, Cell, 158, 15, 10.1016/j.cell.2014.06.008 · DOI · Paper page
- Pandya, 2017, Differentiation of human and murine induced pluripotent stem cells to microglia-like cells, Nat Neurosci, 20, 753, 10.1038/nn.4534 · DOI · Paper page
- Muffat, 2016, Efficient derivation of microglia-like cells from human pluripotent stem cells, Nat Med, 22, 1358, 10.1038/nm.4189 · DOI · Paper page
- Douvaras, 2017, Directed differentiation of human pluripotent stem cells to microglia, Stem Cell Rep, 8, 1516, 10.1016/j.stemcr.2017.04.023 · DOI · Paper page
- Abud, 2017, iPSC-derived human microglia-like cells to study neurological diseases, Neuron, 94, 278, 10.1016/j.neuron.2017.03.042 · DOI · Paper page
- Takata, 2017, Induced-pluripotent-stem-cell-derived primitive macrophages provide aplatform for modeling tissue-resident macrophage differentiation and function, Immunity, 47, 183, 10.1016/j.immuni.2017.06.017 · DOI
- Brownjohn, 2018, Functional studies of missense TREM2 mutations in human stem cell-derived microglia, Stem Cell Rep, 10, 1294, 10.1016/j.stemcr.2018.03.003 · DOI · Paper page
- Amos PJ , Fung S , Case A , Kifelew J , Osnis L , Smith CL , Green K , Naydenov A , Aloi M , Hubbard JJ , Ramakrishnan A , Garden GA , Jayadev S (2017) Modulation of hematopoietic lineage specification impacts TREM2 expression in microglia-like cells derived from human stem cells. ASN Neuro 9, 1759091417716610. · DOI
- Scheltens, 2016, Alzheimer’s disease, Lancet, 388, 505, 10.1016/S0140-6736(15)01124-1 · DOI · Paper page
- Heneka, 2015, Neuroinflammationin Alzheimer’s disease, Lancet Neurol, 14, 388, 10.1016/S1474-4422(15)70016-5 · DOI · Paper page
- Nasica-Labouze, 2015, Amyloid beta protein and Alzheimer’s disease: When computer simulations complement experimental studies, Chem Rev, 115, 3518, 10.1021/cr500638n · DOI
- Keren-Shaul, 2017, A unique microglia type associated with restricting development of Alzheimer’s disease, Cell, 169, 1276, 10.1016/j.cell.2017.05.018 · DOI · Paper page
- Yang, 2011, Mechanism mediating oligomeric Abeta clearance by naive primary microglia, Neurobiol Dis, 42, 221, 10.1016/j.nbd.2011.01.005 · DOI · Paper page
- Spangenberg, 2017, Inflammation in Alzheimer’s disease: Lessons learned from microglia-depletion models, Brain Behav Immun, 61, 1, 10.1016/j.bbi.2016.07.003 · DOI · Paper page
- Takahashi, 2006, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell, 126, 663, 10.1016/j.cell.2006.07.024 · DOI · Paper page
- Hinze, 2011, Differentiation of mouse bone marrow derived stem cells toward microglia-like cells, BMC Cell Biol, 12, 35, 10.1186/1471-2121-12-35 · DOI
- Etemad, 2012, A novel in vitro human microglia model: Characterization of human monocyte-derived microglia, J Neurosci Methods, 209, 79, 10.1016/j.jneumeth.2012.05.025 · DOI
- Bennett, 2016, New tools for studying microglia in the mouse and human CNS, Proc Natl Acad Sci USA, 113, E1738, 10.1073/pnas.1525528113 · DOI · Paper page
- Singleton, 1996, Insulinlike growth factor I receptor prevents apoptosis and enhances neuroblastoma tumorigenesis, Cancer Res, 56, 4522
- Halle, 2008, The NALP3 inflammasome is involved in the innate immune response to amyloid-beta, Nat. Immunol, 9, 857, 10.1038/ni.1636 · DOI · Paper page
- Bornemann, 2001, Abeta-induced inflammatory processes in microglia cells of APP23 transgenic mice, Am J Pathol, 158, 63, 10.1016/S0002-9440(10)63945-4 · DOI
- 10.1002/cne.24484 · DOI
- Lue, 2010, Microglia activation and anti-inflammatory regulation in Alzheimer’s disease, Mol Neurobiol, 41, 115, 10.1007/s12035-010-8106-8 · DOI
- Neniskyte, 2013, Lactadherin/MFG-E8 is essential for microglia-mediated neuronal loss and phagoptosis induced by amyloid ß, J Neurochem, 126, 312, 10.1111/jnc.12288 · DOI
- Ji, 2007, Resident microglia die and infiltrated neu-trophils and monocytes become major inflammatory cells in lipopolysaccharide-injected brain, Glia, 55, 1577, 10.1002/glia.20571 · DOI
- Miwa, 1997, Lipopolysaccharide enhances synthesis of brain-derived neurotrophic factor in cultured rat microglia, J Neurosci Res, 50, 1023, 10.1002/(SICI)1097-4547(19971215)50:6<1023::AID-JNR13>3.0.CO;2-5 · DOI
- Elkabes, 1998, Lipopolysaccharide differentially regulates microglial trk receptor and neu-rotrophin expression, J Neurosci Res, 54, 117, 10.1002/(SICI)1097-4547(19981001)54:1<117::AID-JNR12>3.0.CO;2-4 · DOI
- Bartlett, 2013, P2X7 receptor activation induces reactive oxygen species formation and cell death in murine EOC13 microglia, Mediators Inflamm, 2013, 271813, 10.1155/2013/271813 · DOI
- Qin, 2017, Presenilin 2 deficiency facilitates Aß-induced neuroinflammation and injury by upregulating P2X7 expression, Sci China Life Sci, 60, 189, 10.1007/s11427-016-0347-4 · DOI
- 10.1038/s41380-018-0108-3 · DOI · Paper page
- Sugiura, 2014, Induced pluripotent stem cell generation-associated point mutations arise during the initial stages of the conversion of these cells, Stem Cell Rep, 2, 52, 10.1016/j.stemcr.2013.11.006 · DOI
- Young, 2012, Background mutations in parental cells account for most of the genetic heterogeneity of induced pluripotent stem cells, Cell Stem Cell, 10, 570, 10.1016/j.stem.2012.03.002 · DOI
- Mills, 2013, Clonal genetic and hematopoietic heterogeneity among human-induced pluripotent stem cell lines, Blood, 122, 2047, 10.1182/blood-2013-02-484444 · DOI
Cited by
Sorted by citations
Modeling Alzheimer’s disease with iPSC-derived brain cells
Penney, J., Ralvenius, W. T., & Tsai, L.-H. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0468-3 · Cited by 471
Penning, A., Snoeck, S., Ormaechea, O. R., Ayyildiz, D., Polzer, O., Buitrago-Arango, M., Capobianco, R., de Winter, F., Balusu, S., Verhaagen, J., et al. (2026) · Acta Neuropathologica Communications · doi:10.1186/s40478-026-02228-8 · Cited by 6
Metadata
- Authors
- Xu, M., Zhang, L., Liu, G., Jiang, N., Zhou, W., & Zhang, Y.
- Affiliations
- Beijing Institute of Pharmacology and Toxicology, Beijing, P.R. China
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2019-01-08
- Volume
- 67
- Issue
- 1
- Pages
- 357-368
- ISSN
- 1387-2877
- 1875-8908
- Cited by
- 39
- References
- 12
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review